Found: 11
Select item for more details and to access through your institution.
Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 8, p. 7517, doi. 10.3390/ijms24087517
- By:
- Publication type:
- Article
Repeated Previous Transarterial Treatments Negatively Affect Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib.
- Published in:
- Gastroenterology Insights, 2024, v. 15, n. 3, p. 519, doi. 10.3390/gastroent15030038
- By:
- Publication type:
- Article
A Case of Advanced Hepatocellular Carcinoma with Bone Metastases Managed with Tyrosine Kinase Inhibitors and Aggressive Palliative Radiation Therapy: Role of Combination Therapy for Extending Survival.
- Published in:
- Gastroenterology Insights, 2023, v. 14, n. 1, p. 38, doi. 10.3390/gastroent14010005
- By:
- Publication type:
- Article
Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular Carcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 5, p. 1523, doi. 10.3390/cancers15051523
- By:
- Publication type:
- Article
Impact of body mass index on the prognosis of unresectable HCC patients receiving first‐line Lenvatinib or atezolizumab plus bevacizumab.
- Published in:
- Liver International, 2024, v. 44, n. 5, p. 1108, doi. 10.1111/liv.15885
- By:
- Publication type:
- Article
Association between anatomic variations of extrahepatic and intrahepatic bile ducts: Do look up!
- Published in:
- Journal of Anatomy, 2023, v. 242, n. 4, p. 683, doi. 10.1111/joa.13808
- By:
- Publication type:
- Article
RANK–RANKL–OPG Axis in MASLD: Current Evidence Linking Bone and Liver Diseases and Future Perspectives.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 17, p. 9193, doi. 10.3390/ijms25179193
- By:
- Publication type:
- Article
Effects of COVID-19 Pandemic on Metabolic Status and Psychological Correlates of a Cohort of Italian NAFLD Outpatients.
- Published in:
- Nutrients, 2023, v. 15, n. 6, p. 1445, doi. 10.3390/nu15061445
- By:
- Publication type:
- Article
Very Low Alcohol Consumption Is Associated with Lower Prevalence of Cirrhosis and Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease.
- Published in:
- Nutrients, 2022, v. 14, n. 12, p. 2493, doi. 10.3390/nu14122493
- By:
- Publication type:
- Article
Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy.
- Published in:
- Current Oncology, 2024, v. 31, n. 1, p. 547, doi. 10.3390/curroncol31010038
- By:
- Publication type:
- Article
Prediction of cardiovascular risk in patients with hepatocellular carcinoma receiving anti-angiogenic drugs: lessons from sorafenib.
- Published in:
- Internal & Emergency Medicine, 2024, v. 19, n. 4, p. 1151, doi. 10.1007/s11739-024-03578-8
- By:
- Publication type:
- Article